Thrust & Parry: CVT And Gilead Look To Lock Out Astellas With Planned Merger

Gilead’s surprise $20 per share bid tops Astellas’ $16 per share offer, highlights Gilead’s increasing focus on cardiovascular space.

More from Archive

More from Pink Sheet